Literature DB >> 12041918

Effect of centrally injected allopregnanolone on sexual receptivity, luteinizing hormone release, hypothalamic dopamine turnover, and release in female rats.

Myriam R Laconi1, Ricardo J Cabrera.   

Abstract

The effect of intracerebroventricular (icv) injection of allopregnanolone (5alpha-pregnan-3alpha-ol-20-one) on the dopaminergic and reproductive function in ovariectomized rats primed with estrogen and progesterone was investigated. Thirty minutes after icv allopregnanolone injection, the sexual receptivity, luteinizing hormone (LH) release, dopamine content, and release in the medial basal hypothalamus (MBH) and preoptic area (POA) were determined. After allopregnanolone injection, LH serum levels were reduced (p < 0.001) and lordosis behavior was inhibited (p < 0.005). Intracerebroventricular injection of bicuculline (a gamma-aminobutyric acidA [GABAA] antagonist) alone was ineffective. The injection of allopregnanolone plus bicuculline blocked the effects of allopregnanolone on sexual receptivity and on LH serum levels. At the same time, endogenous dopamine concentration in both the MBH and POA was augmented (p < 0.005 and p < 0.006, respectively) and the turnover rate decreased in both structures. Moreover, in vitro 3H-dopamine release from MBH and POA was lower in rats injected with allopregnanolone in comparison with vehicle-treated rats. These results suggest that allopregnanolone influences the dopaminergic mechanisms in female rats, which may, in turn, be responsible for the reduced reproductive activity. Allopregnanolone may exert its effects on sexual behavior through GABAA receptor modulation and a decrease in dopaminergic activity in the MBH and POA. These actions could explain the inhibition of LH release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12041918     DOI: 10.1385/ENDO:17:2:077

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

Review 1.  [Neurosteroids: behavioral aspects and physiological implications].

Authors:  Y Akwa; E E Baulieu
Journal:  J Soc Biol       Date:  1999

Review 2.  Neuroendocrine regulation of pulsatile luteinizing hormone release in the rat.

Authors:  R V Gallo
Journal:  Neuroendocrinology       Date:  1980       Impact factor: 4.914

3.  Receptivity, proceptivity and attractivity of pregnant and pseudopregnant rats.

Authors:  W J de Greef; J A Merkx
Journal:  Behav Brain Res       Date:  1982-02       Impact factor: 3.332

4.  Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats.

Authors:  W R Crowley
Journal:  Brain Res       Date:  1988-10-04       Impact factor: 3.252

5.  Turnover rate and stimulus-evoked release of dopamine by progesterone and N-methyl-D-aspartic acid in rat striatum during pregnancy.

Authors:  R J Cabrera; C Bregonzio
Journal:  Eur J Pharmacol       Date:  1996-12-12       Impact factor: 4.432

6.  The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor.

Authors:  A E Calogero; M A Palumbo; A M Bosboom; N Burrello; E Ferrara; G Palumbo; F Petraglia; R D'Agata
Journal:  J Endocrinol       Date:  1998-07       Impact factor: 4.286

7.  In vitro release of luteinizing hormone-releasing hormone (LHRH) from rat mediobasal hypothalamus: effects of potassium, calcium and dopamine.

Authors:  W H Rotsztejn; J L Charli; E Pattou; J Epelbaum; C Kordon
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

Review 8.  Regulation of luteinizing hormone-releasing hormone and luteinizing hormone secretion by hypothalamic amino acids.

Authors:  A O Donoso; A M Seltzer; C E Navarro; R J Cabrera; F J López; A Negro-Vilar
Journal:  Braz J Med Biol Res       Date:  1994-04       Impact factor: 2.590

9.  Evidence for gamma-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat.

Authors:  B A Adler; W R Crowley
Journal:  Endocrinology       Date:  1986-01       Impact factor: 4.736

10.  Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion.

Authors:  E Fuchs; T Mansky; K W Stock; E Vijayan; W Wuttke
Journal:  Neuroendocrinology       Date:  1984-06       Impact factor: 4.914

View more
  6 in total

1.  Allopregnanolone induces LHRH and glutamate release through NMDA receptor modulation.

Authors:  Fernando A Giuliani; Roberto Yunes; Claudia E Mohn; Myriam Laconi; Valeria Rettori; Ricardo Cabrera
Journal:  Endocrine       Date:  2011-03-31       Impact factor: 3.633

2.  NMDA receptors in the medial zona incerta stimulate luteinizing hormone and prolactin release.

Authors:  Claudia Bregonzio; Griselda N Moreno; Ricardo J Cabrera; Alfredo O Donoso
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

3.  The Neurosteroid Progesterone Underlies Estrogen Positive Feedback of the LH Surge.

Authors:  Paul Micevych; Kevin Sinchak
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-02       Impact factor: 5.555

Review 4.  Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Authors:  HuaLin Cai; Ting Cao; Xiang Zhou; Jeffrey K Yao
Journal:  Front Psychiatry       Date:  2018-03-08       Impact factor: 4.157

5.  Allopregnanolone alters follicular and luteal dynamics during the estrous cycle.

Authors:  Joana Antonela Asensio; Antonella Rosario Ramona Cáceres; Laura Tatiana Pelegrina; María de Los Ángeles Sanhueza; Leopoldina Scotti; Fernanda Parborell; Myriam Raquel Laconi
Journal:  Reprod Biol Endocrinol       Date:  2018-04-10       Impact factor: 5.211

6.  Dynorphin and GABAA Receptor Signaling Contribute to Progesterone's Inhibition of the LH Surge in Female Mice.

Authors:  Yali Liu; Xiaofeng Li; Deyana Ivanova; Geffen Lass; Wen He; Qiuju Chen; Sha Yu; Yun Wang; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang; Kevin T O'Byrne
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.